DNDN is off almost 50% from its May high. The ASCO presentations by JNJ and MDVN clearly didn’t help, but one might have thought these data were largely baked into DNDN’s share price already.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.